{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:46:23Z","timestamp":1790063183108,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic lupus erythematosus (SLE) has a complex, multifactorial etiology, which contributes to a lack of definitive cure and limited treatment efficacy. Here, we report that cyclic GMP-AMP synthase (cGAS) is significantly activated in SLE patients. We further demonstrate that cGAS deletion protects mice from lupus-like symptoms induced by the TLR7 agonist imiquimod (IMQ). In a screen of 3,159 FDA-approved drugs, we identify the antiplatelet agent prasugrel as a potent cGAS inhibitor. Mechanistically, prasugrel disrupts the DNA-triggered liquid phase condensation and activation of cGAS via direct acetylation. Strikingly, we find that prasugrel exhibits remarkable efficacy in treating SLE in both mouse models and patient cells. Importantly, we report elevated plasma cyclic GMP-AMP (cGAMP) in SLE patients and identify it as a potential biomarker for predicting prasugrel response. Thus, our work elucidates the essential role of cGAS in SLE pathogenesis and presents prasugrel as a promising therapeutic option with immediate translational potential.<\/jats:p>","DOI":"10.1038\/s41467-026-70794-5","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T18:48:33Z","timestamp":1773859713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prasugrel inhibits TLR7-driven autoimmunity in systemic lupus erythematosus by acetylating cGAS"],"prefix":"10.1038","volume":"17","author":[{"given":"Zeng-Lin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6180-4924","authenticated-orcid":false,"given":"Li-Ming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7401-9332","authenticated-orcid":false,"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Zhen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen-Chao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9633-4557","authenticated-orcid":false,"given":"Xucheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Peng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-508X","authenticated-orcid":false,"given":"Yu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1371-7309","authenticated-orcid":false,"given":"Zhuoxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7737-5597","authenticated-orcid":false,"given":"Jiaqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0207-4532","authenticated-orcid":false,"given":"Xue-Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6222-2053","authenticated-orcid":false,"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2590-6242","authenticated-orcid":false,"given":"Zhanguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5873-6422","authenticated-orcid":false,"given":"Qiong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-2973","authenticated-orcid":false,"given":"Xinhua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0746-8322","authenticated-orcid":false,"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"70794_CR1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","volume":"12","author":"GC Tsokos","year":"2016","unstructured":"Tsokos, G. C., Lo, M. S., Costa Reis, P. & Sullivan, K. E. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat. Rev. Rheumatol. 12, 716\u2013730 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"70794_CR2","doi-asserted-by":"crossref","unstructured":"Kaul, A. et al. Systemic lupus erythematosus. Nat. Rev. Dis. Primers 2 (2016).","DOI":"10.1038\/nrdp.2016.39"},{"key":"70794_CR3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41584-021-00739-3","volume":"18","author":"AR Parra S\u00e1nchez","year":"2022","unstructured":"Parra S\u00e1nchez, A. R., Voskuyl, A. E. & van Vollenhoven, R. F. Treat-to-target in systemic lupus erythematosus: advancing towards its implementation. Nat. Rev. Rheumatol. 18, 146\u2013157 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"70794_CR4","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1016\/j.cell.2021.07.021","volume":"184","author":"S Caielli","year":"2021","unstructured":"Caielli, S. et al. Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE. Cell. 184, 4464\u20134479.e4419 (2021).","journal-title":"Cell"},{"key":"70794_CR5","doi-asserted-by":"crossref","unstructured":"Psarras A., Wittmann M., Vital E. M. Emerging concepts of type I interferons in SLE pathogenesis and therapy. Nat. Rev. Rheumatol. 18, 575\u2013590 (2022).","DOI":"10.1038\/s41584-022-00826-z"},{"key":"70794_CR6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","volume":"22","author":"YJ Crow","year":"2021","unstructured":"Crow, Y. J. & Stetson, D. B. The type I interferonopathies: 10 years on. Nat. Rev. Immunol. 22, 471\u2013483 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"70794_CR7","doi-asserted-by":"crossref","unstructured":"Ablasser A. & Chen Z. J. cGAS in action: expanding roles in immunity and inflammation. Science. 363, eaat8657 (2019).","DOI":"10.1126\/science.aat8657"},{"key":"70794_CR8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-immunol-031210-101340","volume":"29","author":"R Barbalat","year":"2011","unstructured":"Barbalat, R., Ewald, S. E., Mouchess, M. L. & Barton, G. M. Nucleic acid recognition by the innate immune system. Annu. Rev. Immunol. 29, 185\u2013214 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"70794_CR9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","volume":"339","author":"J Wu","year":"2013","unstructured":"Wu, J. et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 339, 826\u2013830 (2013).","journal-title":"Science"},{"key":"70794_CR10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786\u2013791 (2013).","journal-title":"Science"},{"key":"70794_CR11","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1073\/pnas.0900850106","volume":"106","author":"W Sun","year":"2009","unstructured":"Sun, W. et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl. Acad. Sci. USA 106, 8653\u20138658 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70794_CR12","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1128\/MCB.00640-08","volume":"28","author":"L Jin","year":"2023","unstructured":"Jin, L. et al. MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals. Mol. Cell. Biol. 28, 5014\u20135026 (2023).","journal-title":"Mol. Cell. Biol."},{"key":"70794_CR13","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","volume":"455","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674\u2013678 (2008).","journal-title":"Nature"},{"key":"70794_CR14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.immuni.2008.09.003","volume":"29","author":"B Zhong","year":"2008","unstructured":"Zhong, B. et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29, 538\u2013550 (2008).","journal-title":"Immunity"},{"key":"70794_CR15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41581-022-00589-6","volume":"18","author":"S Skopelja-Gardner","year":"2022","unstructured":"Skopelja-Gardner, S., An, J. & Elkon, K. B. Role of the cGAS\u2013STING pathway in systemic and organ-specific diseases. Nat. Rev. Nephrol. 18, 558\u2013572 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"70794_CR16","doi-asserted-by":"crossref","unstructured":"Gao, D. et al. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases. Proc. Natl. Acad. Sci. 112, 5699\u20135705 (2015).","DOI":"10.1073\/pnas.1516465112"},{"key":"70794_CR17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","volume":"183","author":"C-H Yu","year":"2020","unstructured":"Yu, C.-H. et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS. Cell 183, 636\u2013649.e618 (2020).","journal-title":"Cell"},{"key":"70794_CR18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nri.2017.21","volume":"17","author":"AP West","year":"2017","unstructured":"West, A. P. & Shadel, G. S. Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat. Rev. Immunol. 17, 363\u2013375 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"70794_CR19","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4049\/jimmunol.1500969","volume":"195","author":"EE Gray","year":"2015","unstructured":"Gray, E. E., Treuting, P. M., Woodward, J. J. & Stetson, D. B. Cutting Edge: cGAS is required for lethal autoimmune disease in the Trex1-deficient mouse model of aicardi\u2013gouti\u00e8res syndrome.  J. Immunol. 195, 1939\u20131943 (2015).","journal-title":"J. Immunol."},{"key":"70794_CR20","doi-asserted-by":"crossref","first-page":"19655","DOI":"10.1074\/jbc.274.28.19655","volume":"274","author":"DJ Mazur","year":"1999","unstructured":"Mazur, D. J. & Perrino, F. W. Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3\u2032\u2013>5\u2032 exonucleases. J. Biol. Chem. 274, 19655\u201319660 (1999).","journal-title":"J. Biol. Chem."},{"key":"70794_CR21","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1093\/emboj\/18.13.3868","volume":"18","author":"M H\u00f6ss","year":"1999","unstructured":"H\u00f6ss, M. et al. A human DNA editing enzyme homologous to the Escherichia coli DnaQ\/MutD protein. Embo J. 18, 3868\u20133875 (1999).","journal-title":"Embo J."},{"key":"70794_CR22","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1074\/jbc.M700039200","volume":"282","author":"U de Silva","year":"2007","unstructured":"de Silva, U. et al. The crystal structure of TREX1 explains the 3\u2032 nucleotide specificity and reveals a polyproline II helix for protein partnering. J. Biol. Chem. 282, 10537\u201310543 (2007).","journal-title":"J. Biol. Chem."},{"key":"70794_CR23","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","volume":"39","author":"MA Lee-Kirsch","year":"2007","unstructured":"Lee-Kirsch, M. A. et al. Mutations in the gene encoding the 3\u2032\u22125\u2032 DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39, 1065\u20131067 (2007).","journal-title":"Nat. Genet."},{"key":"70794_CR24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajmg.a.36887","volume":"167a","author":"YJ Crow","year":"2015","unstructured":"Crow, Y. J. et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am. J. Med. Genet. A 167a, 296\u2013312 (2015).","journal-title":"Am. J. Med. Genet. A"},{"key":"70794_CR25","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ng1845","volume":"38","author":"YJ Crow","year":"2006","unstructured":"Crow, Y. J. et al. Mutations in the gene encoding the 3\u2032\u22125\u2032 DNA exonuclease TREX1 cause Aicardi-Gouti\u00e8res syndrome at the AGS1 locus. Nat. Genet. 38, 917\u2013920 (2006).","journal-title":"Nat. Genet."},{"key":"70794_CR26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","volume":"15","author":"YJ Crow","year":"2015","unstructured":"Crow, Y. J. & Manel, N. Aicardi-Goutieres syndrome and the type I interferonopathies. Nat. Rev. Immunol. 15, 429\u2013440 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"70794_CR27","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cell.2019.01.016","volume":"176","author":"J Dai","year":"2019","unstructured":"Dai, J. et al. Acetylation blocks cGAS activity and inhibits Self-DNA-induced autoimmunity. Cell 176, 1447\u20131460.e1414 (2019).","journal-title":"Cell"},{"key":"70794_CR28","doi-asserted-by":"crossref","unstructured":"Motwani, M. et al. cGAS-STING pathway does not promote autoimmunity in murine models of SLE. Front. Immunol. 12, 605930 (2021).","DOI":"10.3389\/fimmu.2021.605930"},{"key":"70794_CR29","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.40002","volume":"69","author":"J An","year":"2017","unstructured":"An, J. et al. Expression of cyclic GMP-AMP synthase in patients with systemic lupus erythematosus. Arthritis Rheumatol. 69, 800\u2013807 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"70794_CR30","doi-asserted-by":"crossref","first-page":"15838","DOI":"10.1073\/pnas.1001337107","volume":"107","author":"N Shen","year":"2010","unstructured":"Shen, N. et al. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 107, 15838\u201315843 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70794_CR31","doi-asserted-by":"crossref","first-page":"eadi9575","DOI":"10.1126\/sciimmunol.adi9575","volume":"9","author":"H Mishra","year":"2024","unstructured":"Mishra, H. et al. Disrupted degradative sorting of TLR7 is associated with human lupus. Sci. Immunol. 9, eadi9575 (2024).","journal-title":"Sci. Immunol."},{"key":"70794_CR32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","volume":"605","author":"GJ Brown","year":"2022","unstructured":"Brown, G. J. et al. TLR7 gain-of-function genetic variation causes human lupus. Nature 605, 349\u2013356 (2022).","journal-title":"Nature"},{"key":"70794_CR33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","volume":"3","author":"H Hemmi","year":"2002","unstructured":"Hemmi, H. et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88\u2013dependent signaling pathway. Nat. Immunol. 3, 196\u2013200 (2002).","journal-title":"Nat. Immunol."},{"key":"70794_CR34","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.38298","volume":"66","author":"M Yokogawa","year":"2014","unstructured":"Yokogawa, M. et al. Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic lupus erythematosus. Arthritis Rheumatol. 66, 694\u2013706 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"70794_CR35","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMoa1110556","volume":"366","author":"C Harrison","year":"2012","unstructured":"Harrison, C. et al. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N. Engl. J. Med. 366, 787\u2013798 (2012).","journal-title":"N. Engl. J. Med."},{"key":"70794_CR36","volume":"8","author":"J Vincent","year":"2017","unstructured":"Vincent, J. et al. Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice. Nat. Commun. 8, 750 (2017).","journal-title":"Nat. Commun."},{"key":"70794_CR37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.120.000275","volume":"376","author":"J Vlach","year":"2021","unstructured":"Vlach, J. et al. Discovery of M5049: a novel selective toll-like receptor 7\/8 Inhibitor for treatment of autoimmunity. J. Pharm. Exp. Ther. 376, 397\u2013409 (2021).","journal-title":"J. Pharm. Exp. Ther."},{"key":"70794_CR38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41586-023-06621-4","volume":"622","author":"S Victorelli","year":"2023","unstructured":"Victorelli, S. et al. Apoptotic stress causes mtDNA release during senescence and drives the SASP. Nature 622, 627\u2013636 (2023).","journal-title":"Nature"},{"key":"70794_CR39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.chembiol.2017.03.011","volume":"24","author":"X Niu","year":"2017","unstructured":"Niu, X. et al. A small-molecule inhibitor of bax and bak oligomerization prevents genotoxic cell death and promotes neuroprotection. Cell Chem. Biol. 24, 493\u2013506.e495 (2017).","journal-title":"Cell Chem. Biol."},{"key":"70794_CR40","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ni1087","volume":"5","author":"M Yoneyama","year":"2004","unstructured":"Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730\u2013737 (2004).","journal-title":"Nat. Immunol."},{"key":"70794_CR41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","volume":"441","author":"H Kato","year":"2006","unstructured":"Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101\u2013105 (2006).","journal-title":"Nature"},{"key":"70794_CR42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","volume":"20","author":"J Rehwinkel","year":"2020","unstructured":"Rehwinkel, J. & Gack, M. U. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat. Rev. Immunol. 20, 537\u2013551 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"70794_CR43","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1126\/science.aat1022","volume":"361","author":"M Du","year":"2018","unstructured":"Du, M. & Chen, Z. J. DNA-induced liquid phase condensation of cGAS activates innate immune signaling. Science 361, 704\u2013709 (2018).","journal-title":"Science"},{"key":"70794_CR44","doi-asserted-by":"crossref","unstructured":"Zhao, M. et al. The stress granule protein G3BP1 promotes pre-condensation of cGAS to allow rapid responses to DNA. EMBO Rep. 23, e53166 (2021).","DOI":"10.15252\/embr.202153166"},{"key":"70794_CR45","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08620-4","volume":"10","author":"L Lama","year":"2019","unstructured":"Lama, L. et al. Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression. Nat. Commun. 10, 2261 (2019).","journal-title":"Nat. Commun."},{"key":"70794_CR46","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separation. Nat. Commun. 14, 6132 (2023).","journal-title":"Nat. Commun."},{"key":"70794_CR47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1527-3466.2007.00027.x","volume":"25","author":"JA Jakubowski","year":"2007","unstructured":"Jakubowski, J. A., Winters, K. J., Naganuma, H. & Wallentin, L. Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile. Cardiovasc. Drug Rev. 25, 357\u2013374 (2007).","journal-title":"Cardiovasc. Drug Rev."},{"key":"70794_CR48","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41590-020-0743-0","volume":"21","author":"D Nehar-Belaid","year":"2020","unstructured":"Nehar-Belaid, D. et al. Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat. Immunol. 21, 1094\u20131106 (2020).","journal-title":"Nat. Immunol."},{"key":"70794_CR49","doi-asserted-by":"crossref","first-page":"eadi9769","DOI":"10.1126\/sciimmunol.adi9769","volume":"9","author":"C Wolf","year":"2024","unstructured":"Wolf, C. et al. UNC93B1 variants underlie TLR7-dependent autoimmunity. Sci. Immunol. 9, eadi9769 (2024).","journal-title":"Sci. Immunol."},{"key":"70794_CR50","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1101\/gr.265249.120","volume":"31","author":"B Panwar","year":"2021","unstructured":"Panwar, B. et al. Multi\u2013cell type gene coexpression network analysis reveals coordinated interferon response and cross\u2013cell type correlations in systemic lupus erythematosus. Genome Res. 31, 659\u2013676 (2021).","journal-title":"Genome Res."},{"key":"70794_CR51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","volume":"18","author":"Y Tanaka","year":"2022","unstructured":"Tanaka, Y., Luo, Y., O\u2019Shea, J. J. & Nakayamada, S. Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach. Nat. Rev. Rheumatol. 18, 133\u2013145 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"70794_CR52","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","volume":"20","author":"MM Attwood","year":"2021","unstructured":"Attwood, M. M., Fabbro, D., Sokolov, A. V., Knapp, S. & Schi\u00f6th, H. B. Trends in kinase drug discovery: targets, indications and inhibitor design. Nat. Rev. Drug Discov. 20, 839\u2013861 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70794_CR53","doi-asserted-by":"crossref","unstructured":"Meroni, P. L. & Tsokos, G. C. Editorial: systemic lupus erythematosus and antiphospholipid syndrome. Front. Immunol. 10, 199 (2019).","DOI":"10.3389\/fimmu.2019.00199"},{"key":"70794_CR54","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout, A., Katz, J. D., Venkatraman, S. & Ablasser, A. The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol. 21, 548\u2013569 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"70794_CR55","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"K-P Hopfner","year":"2020","unstructured":"Hopfner, K.-P. & Hornung, V. Molecular mechanisms and cellular functions of cGAS\u2013STING signalling. Nat. Rev. Mol. Cell Biol. 21, 501\u2013521 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"70794_CR56","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm.4450","volume":"24","author":"N Kerur","year":"2017","unstructured":"Kerur, N. et al. cGAS drives noncanonical-inflammasome activation in age-related macular degeneration. Nat. Med. 24, 50\u201361 (2017).","journal-title":"Nat. Med."},{"key":"70794_CR57","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","volume":"620","author":"MF Gulen","year":"2023","unstructured":"Gulen, M. F. et al. cGAS\u2013STING drives ageing-related inflammation and neurodegeneration. Nature 620, 374\u2013380 (2023).","journal-title":"Nature"},{"key":"70794_CR58","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216\u2013w221 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70794-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70794-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70794-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T15:06:57Z","timestamp":1778425617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70794-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70794"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70794-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4147"}}